In addition to Epo methylation, a variety of pathogenetic factors in CKD including inflammation, endoplasmic reticulum stress, oxidative stress and uremic toxin have been shown to reduce EPO production in the cell or animal models [1, 2, 15–20]. Here, EPO is linked to chronic kidney disease.